Archana Jayakumar
Sleep Medicine · Summit, NJNPI 1780145383
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 56.4% of the total. Reporting peaked in 2023 at $1,160 and has fallen 60.7% since, to $456 in 2025.
Across 58 payments — averaging $33.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$1K
- GSK$151
- Avadel CNS Pharmaceuticals, LLC$96
- Harmony Biosciences LLC$92
- AstraZeneca$81
- Jazz Pharmaceuticals Inc.$64
- plus $362 from 14 others
What the payments were for
- Consulting fees$191%
- Travel & lodging$80241%
- Food & beverage$1,12258%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$948
How this compares
$1,943 in reported general payments places this provider in the 55th percentile of 40 sleep medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 120 | $1,745 |
| Azelastine Hcl | 27 | $601 |
| Mirtazapine | 32 | $493 |
| Eszopiclone | 15 | $440 |
| Zaleplon | 24 | $398 |
| Zolpidem Tartrate | 12 | $64 |
| Trazodone Hcl | 11 | $33 |
| Alprazolam | 12 | $8 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Summit
- Federico CerroneSummit$13K
- William WeberSummit$746
- Jeffrey NahmiasSummit$451
- Prashant PatelBridgewater$20K
- Nehal MehtaBridgewater$19K
- Thanuja HamiltonMount Laurel$9K
- Jimmy HannaNewark$7K
- Tanuj BhatnagarJersey City$7K
- Bankim ShahBoonton$7K
- Kalpeshkumar PatelOld Bridge$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.